Skip to contentS
SI-BONE, Inc.
S
SIBNSI-BONE, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$25.23M$25.23Mderived+13.9% vs Q4 2020 Net Income-$14.48M-$14.48MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SI-BONE, Inc. · CIK 1459839 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$21,855,000+10.0% Operating Incomederived-$13,931,000N/M Operating Cash Flowderived-$12,714,000N/M Free Cash Flowderived-$14,489,000N/M Margins · derivedGross margin86.6%−3.1 pt vs Q4 2020
Operating margin-55.2%−19.7 pt vs Q4 2020
Net margin-57.4%−16.8 pt vs Q4 2020
ended Dec 31, 2021 · filed Mar 1, 2022 · 60 d after period end